From Viking ships to mythical animals, here is the story behind some of the most unusual automotive logos out there.

As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...

CARVYKTI is an autologous T-cell immunotherapy that targets B-cell maturation antigen (BCMA). It works by genetically modifying a patient's T cells with a transgene that encodes a chimeric antigen ...

CARVYKTI is an autologous T-cell immunotherapy that targets B-cell maturation antigen (BCMA). It works by genetically modifying a patient's T cells with a transgene that encodes a chimeric antigen ...

Forbes contributors publish independent expert analyses and insights. Marc Berman is a New York-based reporter who covers media.

Wings Hauser has died (Picture: Bob D’Amico /American Broadcasting Companies via Getty Images) American actor Wings Hauser has died. The star, who was best known for his roles in Vice Squad and ...

Wings Hauser, the father of Cole Hauser and an instantly-recognizable character actor who had roles on just about every action-based TV series in the past 50 years, died over the weekend at the ...

Johnson & Johnson is actively exploring treatment sequences that combine DARZALEX with TECVAYLI, CARVYKTI, and TALVEY. SARCLISA, a newly approved CD38 antibody for multiple myeloma, is gaining ...

4 Here we highlight data supporting the recent 2024 FDA approvals for use of 2 CAR T-cell products in MM, namely cilta-cel (ciltacabtagene autoleucel; Carvykti) and ide-cel (idecabtagene vicleucel; ...

The company’s flagship product, Carvykti, a CAR-T therapy for multiple myeloma, has demonstrated strong efficacy and is driving the company’s growth prospects. This comprehensive analysis examines ...

The company’s flagship product, Carvykti, a CAR-T therapy for multiple myeloma, has demonstrated strong efficacy and is driving the company’s growth prospects. This comprehensive analysis ...